Literature DB >> 4608889

Group B streptococcal neonatal infection.

K A Horn, W T Meyer, B C Wyrick, R A Zimmerman.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4608889

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Experimental group B streptococcal infections in mice: hematogenous virulence and mucosal colonization.

Authors:  D Furtado
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

2.  Group B streptococci: a new threat to the newborn.

Authors:  G Hammersen; K Bartholomé; H C Oppermann; L Wille; P Lutz
Journal:  Eur J Pediatr       Date:  1977-10-12       Impact factor: 3.183

3.  Grouping of beta-haemolytic streptococci with group-specific antibodies absorbed to staphylococcal protein A.

Authors:  G M Tebbutt; D J Coleman; D McGhie
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

Review 4.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

5.  Evaluation of Phadebact and Streptex Kits for rapid grouping of streptococci directly from blood cultures.

Authors:  S Wellstood
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

6.  Further studies on the reliability of the bacitracin inhibition test for the presumptive identification of Lancefield group A streptococci.

Authors:  D J Coleman; D McGhie; G M Tebbutt
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411

7.  Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus.

Authors:  C G Hellerqvist; G B Thurman; D L Page; Y F Wang; B A Russell; C A Montgomery; H W Sundell
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Molecular basis for group B beta-hemolytic streptococcal disease.

Authors:  C G Hellerqvist; H Sundell; P Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 9.  Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy.

Authors:  Kyung-Yil Lee
Journal:  Int J Mol Sci       Date:  2017-02-11       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.